What 5 Analyst Ratings Have To Say About Foghorn Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past three months, five analysts have published their opinions on Foghorn Therapeutics (NASDAQ:FHTX) stock. The analysts have an average price target of $17.8, compared to the current price of $9.2. The current average has decreased by 1.11% from the previous average price target of $18.00.
August 07, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on Foghorn Therapeutics with an average price target of $17.8, implying potential upside.
The bullish outlook from analysts, along with the average price target significantly higher than the current price, suggests potential upside for the stock. This could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100